Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02611024
Title Pharmacokinetic Study of PM01183 in Combination With Irinotecan in Patients With Selected Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors PharmaMar
Indications

lung small cell carcinoma

malignant mesothelioma

endometrial carcinoma

endometrial adenocarcinoma

peritoneum cancer

glioblastoma

sarcoma

ovary epithelial cancer

islet cell tumor

stomach carcinoma

colorectal carcinoma

fallopian tube carcinoma

pancreatic adenocarcinoma

Therapies

Irinotecan + Lurbinectedin

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.